Found 158 chains in Genus chains table. Displaying 1 - 50. Applied filters: Proteins

Search results query: urokinase-type plasminogen activator

Total Genus Sequence Length pdb Title
1 12 6xvdP Crystal structure of complex of urokinase and a upain-1 variant(w3f) in ph7.4 condition
56 247 6xvdU Crystal structure of complex of urokinase and a upain-1 variant(w3f) in ph7.4 condition
56 245 6ag2U Upa-hma
52 245 6ag3U Crystal structure of upa in complex with 3,5-bis(azanyl)-n-carbamimidoyl-6-(2,4-dimethoxypyrimidin-5-yl)pyrazine-2-carboxamide
56 245 6ag7U The crystal structure of upa in complex with hma-55f
54 245 6ag9U Crystal structure of upa in complex with 3,5-bis(azanyl)-6-(1-benzofuran-2-yl)-n-carbamimidoyl-pyrazine-2- carboxamide
0 9 3ig6C Low molecular weigth human urokinase type plasminogen activator 2-[6-(3'-aminomethyl-biphenyl-3-yloxy)-4-(3-dimethylamino-pyrrolidin-1-yl)-3,5-difluoro-pyridin-2-yloxy]-4-dimethylamino-benzoic acid complex
53 259 6nmbA Tranexamic acid is an active site inhibitor of urokinase plasminogen activator
59 245 5z1cU The crystal structure of upa in complex with 4-iodobenzylamine at ph7.4
30 135 5lhnB The catalytic domain of murine urokinase-type plasminogen activator in complex with the allosteric inhibitory nanobody nb7
31 135 5lhpB The p-aminobenzamidine active site inhibited catalytic domain of murine urokinase-type plasminogen activator in complex with the allosteric inhibitory nanobody nb7
53 247 5lhqA The egr-cmk active site inhibited catalytic domain of murine urokinase-type plasminogen activator in complex with the allosteric inhibitory nanobody nb7
33 135 5lhqB The egr-cmk active site inhibited catalytic domain of murine urokinase-type plasminogen activator in complex with the allosteric inhibitory nanobody nb7
29 120 5lhrB The catalytic domain of murine urokinase-type plasminogen activator in complex with the active site binding inhibitory nanobody nb22
48 247 5lhnA The catalytic domain of murine urokinase-type plasminogen activator in complex with the allosteric inhibitory nanobody nb7
56 247 5lhrA The catalytic domain of murine urokinase-type plasminogen activator in complex with the active site binding inhibitory nanobody nb22
54 246 5yc6U The crystal structure of upa in complex with 4-bromobenzylamirne at ph4.6
51 246 5xg4U Crystal structure of upa in complex with quercetin
59 247 4zkoU The crystal structure of upain-1-w3a in complex with upa at ph7.4
0 12 4zknP The crystal structure of upain-1-w3a in complex with upa at ph5.5
1 12 4zksP The crystal structure of upain-1-w3a in complex with inactive upa (upa-s195a) at ph7.4
57 247 4zhlU The crystal structure of mupain-1-ig in complex with murinised human upa at ph7.4
0 10 4zhlP The crystal structure of mupain-1-ig in complex with murinised human upa at ph7.4
0 10 4x1pP The crystal structure of mupain-1-17 in complex with murinised human upa at ph4.6
45 215 4dw2L The crystal structure of upa in complex with the fab fragment of mab-112
38 212 4dw2H The crystal structure of upa in complex with the fab fragment of mab-112
56 246 4dvaU The crystal structure of human urokinase-type plasminogen activator catalytic domain
38 241 4dw2U The crystal structure of upa in complex with the fab fragment of mab-112
53 246 5yc7U The crystal structure of upa in complex with 4-bromobenzylamirne at ph7.4
47 247 5lhpA The p-aminobenzamidine active site inhibited catalytic domain of murine urokinase-type plasminogen activator in complex with the allosteric inhibitory nanobody nb7
59 246 4zknU The crystal structure of upain-1-w3a in complex with upa at ph5.5
58 246 4zksU The crystal structure of upain-1-w3a in complex with inactive upa (upa-s195a) at ph7.4
54 246 4zkrU The crystal structure of upain-1-w3a in complex with upa at ph9.0
37 238 5lhsA The ligand free catalytic domain of murine urokinase-type plasminogen activator
32 128 5hggS Crystal structure of upa in complex with a camelid-derived antibody fragment
59 246 5hggA Crystal structure of upa in complex with a camelid-derived antibody fragment
57 246 4xskU Structure of paitrap, an upa mutant
56 247 4x1pU The crystal structure of mupain-1-17 in complex with murinised human upa at ph4.6
57 245 4os6A Crystal structure of urokinase-type plasminogen activator (upa) complexed with bicyclic peptide uk604 (bicyclic 2)
1 14 4os1B Crystal structure of urokinase-type plasminogen activator (upa) complexed with bicyclic peptide uk601 (bicyclic 1)
58 245 4os2A Crystal structure of urokinase-type plasminogen activator (upa) complexed with bicyclic peptide uk602 (bicyclic 1)
56 245 4os5A Crystal structure of urokinase-type plasminogen activator (upa) complexed with bicyclic peptide uk603 (bicyclic 2)
1 13 4os6B Crystal structure of urokinase-type plasminogen activator (upa) complexed with bicyclic peptide uk604 (bicyclic 2)
1 13 4os2B Crystal structure of urokinase-type plasminogen activator (upa) complexed with bicyclic peptide uk602 (bicyclic 1)
58 245 4os7A Crystal structure of urokinase-type plasminogen activator (upa) complexed with bicyclic peptide uk607 (bicyclic)
1 14 4os5B Crystal structure of urokinase-type plasminogen activator (upa) complexed with bicyclic peptide uk603 (bicyclic 2)
56 245 4os1A Crystal structure of urokinase-type plasminogen activator (upa) complexed with bicyclic peptide uk601 (bicyclic 1)
1 14 4os4B Crystal structure of urokinase-type plasminogen activator (upa) complexed with bicyclic peptide uk603 (bicyclic 1)
1 14 4os7B Crystal structure of urokinase-type plasminogen activator (upa) complexed with bicyclic peptide uk607 (bicyclic)
57 245 4os4A Crystal structure of urokinase-type plasminogen activator (upa) complexed with bicyclic peptide uk603 (bicyclic 1)